OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences

Mar 22, 2012 6:01am EDT

Co-Principal Investigator for OncoSec’s Phase II Merkel Cell Carcinoma Study to Speak at 70th Annual American Academy of Dermatology Meeting

Mar 19, 2012 6:01am EDT

OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial

Mar 14, 2012 6:01am EDT

OncoSec President and CEO Contributes to Today’s Medical Developments

Mar 13, 2012 6:01am EDT

OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy

Mar 08, 2012 6:01am EST

OncoSec’s OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper

Mar 07, 2012 6:01am EST

OncoSec to Present at Cowen and ROTH Healthcare Conferences

Mar 05, 2012 6:01am EST

OncoSec’s OMS ElectroOncology Technology Platform Featured in Medical Device & Diagnostic Industry

Feb 29, 2012 6:01am EST

OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma

Feb 28, 2012 6:01am EST

OncoSec to Present at 10th Annual BioPartnering North America

Feb 24, 2012 6:01am EST